| Name | Title | Contact Details |
|---|
Hexagon Labs is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Union integrates the power of human connection with technology to unite people in the shared experiences of life with chronic health conditions. For almost a decade, Health Union has done the hard work every day to bring people living with chronic conditions together. Through a unique and genuine approach to listening and understanding all aspects of health experiences, Health Union`s open, online communities provide a safe place for people to learn, connect and share. In doing so, social interactions evolve into meaningful health conversations. At the same time, these communities offer healthcare companies countless opportunities to understand how to reach and engage people living with these conditions in smarter, more effective ways. Today, the Health Union family of brands includes online health communities for chronic conditions in a range of categories including primary care, immunology, oncology and neurodegenerative/genetic conditions. Among them are Migraine.com, MultipleSclerosis.net, Endometriosis.net and LungCancer.net to name a few. Health Union is dedicated to making an impact on the lives of people with chronic health concerns. In 2018, that focus has been recognized. The company was named among the top 15 percent of the Inc. 5000 list of fastest-growing private companies in America and topped the list of both Philly.com`s “Top Workplaces” and Philadelphia Business Journal`s “Best Places to Work.”
Argentum is the leading national trade association serving companies that own, operate, and support professionally managed senior living communities in the United States.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
OptiScan Biomedical Corp is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.